Aptsiauri Natalia, Cabrera Teresa, Garcia-Lora Angel, Lopez-Nevot Miguel Angel, Ruiz-Cabello Francisco, Garrido Federico
Servicio de Análisis Clínicos, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Int Rev Cytol. 2007;256:139-89. doi: 10.1016/S0074-7696(07)56005-5.
MHC class I antigens play a crucial role in the interaction of tumor cells with the host immune system, in particular, in the presentation of peptides as tumor-associated antigens to cytotoxic lymphocytes (CTLs) and in the regulation of cytolytic activity of natural killer (NK) cells. In this review we discuss the role of MHC class I antigens in the recognition and elimination of transformed cells and in the generation of tumor immune escape routes when MHC class I losses occur in tumors. The different altered MHC class I phenotypes and their distribution in different human tumors are the main topic of this review. In addition, molecular defects that underlie MHC alterations in transformed cells are also described in detail. Future research directions in this field are also discussed, including the laboratory analysis of tumor MHC class I-negative variants and the possible restoration of MHC class I expression.
MHC I类抗原在肿瘤细胞与宿主免疫系统的相互作用中起着关键作用,特别是在将肽作为肿瘤相关抗原呈递给细胞毒性淋巴细胞(CTL)以及调节自然杀伤(NK)细胞的细胞溶解活性方面。在本综述中,我们讨论了MHC I类抗原在识别和消除转化细胞以及肿瘤发生MHC I类缺失时肿瘤免疫逃逸途径产生中的作用。不同改变的MHC I类表型及其在不同人类肿瘤中的分布是本综述的主要主题。此外,还详细描述了转化细胞中MHC改变的分子缺陷。还讨论了该领域未来的研究方向,包括肿瘤MHC I类阴性变体的实验室分析以及MHC I类表达的可能恢复。